Biotech - Spark Newswire

1 minute read

GSK – Vir Biotech’s Sotrovimab Reduces Hospitalization, Risk Of Death In Adult COVID-19 Patients

Today, 4:54 AM

GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology Inc (NASDAQ:VIR) have announced final, confirmatory results from the Phase 3 COMET-ICE evaluating sotrovimab in high-risk adult…

GSK

1 minute read

Theratechnologies Peptide-Drug Conjugate Shows Better Anti-Metastatic Activity Compared With Docetaxel Alone

By Vandana Singh

Today, 4:54 AM

Theratechnologies Inc (NASDAQ:THTX) has announced new preclinical in vivo findings on its peptide-drug conjugate (PDC), TH1902. The results demonstrate that TH1902…

THTX

1 minute read

Horizon Acquires Rights to Arrowhead’s RNAi-Based Gout Treatment Candidate

By Vandana Singh

Today, 4:54 AM

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) and Horizon Therapeutics plc (NASDAQ:HZNP) have entered into a global collaboration and license agreement for ARO-XDH for uncontrolled gout.…

ARWR

1 minute read

Akero Therapeutics New Analyses For Efruxifermin Shows Rapid, Substantial Liver Fat Reduction In NASH Patients

By Vandana Singh

Today, 4:54 AM

Akero Therapeutics Inc (NASDAQ:AKRO) has announced additional analyses from its Phase 2a BALANCED study of efruxifermin (EFX) in non-alcoholic steatohepatitis (NASH)…

AKRO

1 minute read

Kymera Therapeutics’ KT-413 Shows Encouraging Preclinical Anti-Cancer Activity

By Vandana Singh

Today, 4:54 AM

Kymera Therapeutics Inc (NASDAQ:KYMR) has announced new preclinical data on its IRAKIMiD degrader KT-413’s potential as both a monotherapy and in…

BMS

1 minute read

Agios Pharma Files US Application For Mitapivat In PK Deficiency

By Vandana Singh

Today, 4:54 AM

Agios Pharmaceuticals Inc (NASDAQ:AGIO) has submitted an FDA marketing application seeking approval for mitapivat to treat adults with pyruvate kinase (PK)…

AGIO

1 minute read

Albireo’s Bylvay Shows Further Evidence Of Sustained, Durable Effect In Pediatric Liver Disease Study

By Vandana Singh

Today, 4:54 AM

Albireo Pharma Inc (NASDAQ:ALBO) has announced pooled analysis from Phase 3 PEDFIC studies with Bylvay (odevixibat) and advancement in the characterization…

ALBO

1 minute read

OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China

By Vandana Singh

Today, 4:54 AM

OPKO Health Inc’s (NASDAQ:OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in patients with stage 3/4…

OPK